Teirlinck SRL
Teirlinck reported total assets of 694,347 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jun 2026).
The score of Teirlinck shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -70 % Total assets +180 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Teirlinck's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jun 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 29 Jul 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Teirlinck's financial analysis
- Solvency6.5%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Teirlinck
Teirlinck's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0828.513.424
- VAT number
- BE0828513424
- Peppol
- Registered · 0208:0828513424 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Aug 2010
- Registered office
- 1840 Londerzeel
- Latest accounts
- 2025 · filed on 17 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Teirlinck (SRL) has been based in Londerzeel since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 51,524 € and equity of 45,113 €; its revenue is not published. Its solvency stands at 6.5%, below the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Teirlinck
Companies in the same business, of comparable size and area, outside its group.
- Delvaux Holding Business and other management consultancy activities Herstal · balance sheet €1.10m
- T-Oline Business and other management consultancy activities Ferrières · balance sheet 987,312 €
- Mathis Pharma Business and other management consultancy activities Bruges · balance sheet €1.06m
- Pharmacie Overlo Retail sale of pharmaceutical products Silly · balance sheet 754,243 €
- J&L Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 664,453 €
- V-cares Retail sale of pharmaceutical products Zonhoven · balance sheet €1.07m
- Genappe Pharma Invest Retail sale of pharmaceutical products Genappe · balance sheet €1.21m
- GOME Retail sale of pharmaceutical products Beerse · balance sheet €1.28m
Frequently asked questions about Teirlinck
What is the revenue of Teirlinck?
Teirlinck files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Teirlinck?
In Belgium, the VAT number is the company number prefixed with BE: BE0828513424 for Teirlinck, if the company is VAT-registered. Its company number (CBE) is 0828.513.424.
Where is the registered office of Teirlinck?
According to the CBE register, the registered office of Teirlinck is in 1840 Londerzeel.
What is the equity of Teirlinck?
At the close of the 2025 financial year, the equity of Teirlinck amounts to 45,113 €, a solvency of 6.5% of total assets.
Who manages Teirlinck?
The register lists 1 active mandates at Teirlinck. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Teirlinck
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →